Wealthcare Advisory Partners LLC Makes New $240,000 Investment in Axon Enterprise, Inc $AXON

Wealthcare Advisory Partners LLC purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 290 shares of the biotechnology company’s stock, valued at approximately $240,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $480,000. Harbor Capital Advisors Inc. acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at about $587,000. GAMMA Investing LLC grew its position in shares of Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock valued at $765,000 after acquiring an additional 154 shares during the period. Integrated Advisors Network LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at about $656,000. Finally, CX Institutional acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at about $115,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AXON has been the topic of a number of analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Axon Enterprise in a research report on Wednesday. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an “overweight” rating in a research report on Friday, July 11th. JMP Securities restated a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a research report on Tuesday, August 5th. Finally, JPMorgan Chase & Co. lifted their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a report on Thursday, July 17th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Stock Down 4.2%

AXON stock opened at $703.03 on Friday. The firm has a market cap of $55.19 billion, a PE ratio of 173.59, a PEG ratio of 28.50 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The firm’s 50 day moving average price is $755.57 and its 200-day moving average price is $712.63. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 100 shares of the business’s stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $752.54, for a total value of $75,254.00. Following the sale, the director owned 1,416 shares of the company’s stock, valued at $1,065,596.64. The trade was a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Brittany Bagley sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares in the company, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock valued at $45,115,616 over the last quarter. 4.40% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.